Caroline Gluck1,2, Yi-An Ko1,3, Katalin Susztak4,5. 1. Renal-Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 415 Curie Blvd, 415 Clinical Research Building, Philadelphia, PA, 19104, USA. 2. Division of Nephrology, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA. 3. Department of Genetics Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. 4. Renal-Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 415 Curie Blvd, 415 Clinical Research Building, Philadelphia, PA, 19104, USA. ksusztak@mail.med.upenn.edu. 5. Department of Genetics Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. ksusztak@mail.med.upenn.edu.
Abstract
PURPOSE OF REVIEW: Precision medicine approaches, that tailor medications to specific individuals has made paradigm-shifting improvements for patients with certain cancer types. RECENT FINDINGS: Such approaches, however, have not been implemented for patients with diabetic kidney disease. Precision medicine could offer new avenues for novel diagnostic, prognostic and targeted therapeutics development. Genetic studies associated with multiscalar omics datasets from tissue and cell types of interest of well-characterized cohorts are needed to change the current paradigm. In this review, we will discuss precision medicine approaches that the nephrology community can take to analyze tissue samples to develop new therapeutics for patients with diabetic kidney disease.
PURPOSE OF REVIEW: Precision medicine approaches, that tailor medications to specific individuals has made paradigm-shifting improvements for patients with certain cancer types. RECENT FINDINGS: Such approaches, however, have not been implemented for patients with diabetic kidney disease. Precision medicine could offer new avenues for novel diagnostic, prognostic and targeted therapeutics development. Genetic studies associated with multiscalar omics datasets from tissue and cell types of interest of well-characterized cohorts are needed to change the current paradigm. In this review, we will discuss precision medicine approaches that the nephrology community can take to analyze tissue samples to develop new therapeutics for patients with diabetic kidney disease.
Authors: Monika A Niewczas; Tomohito Gohda; Jan Skupien; Adam M Smiles; William H Walker; Florencia Rosetti; Xavier Cullere; John H Eckfeldt; Alessandro Doria; Tanya N Mayadas; James H Warram; Andrzej S Krolewski Journal: J Am Soc Nephrol Date: 2012-01-19 Impact factor: 10.121
Authors: Marine Germain; Marcus G Pezzolesi; Niina Sandholm; Amy J McKnight; Katalin Susztak; Maria Lajer; Carol Forsblom; Michel Marre; Hans-Henrik Parving; Peter Rossing; Iiro Toppila; Jan Skupien; Ronan Roussel; Yi-An Ko; Nora Ledo; Lasse Folkersen; Mete Civelek; Alexander P Maxwell; David-Alexandre Tregouet; Per-Henrik Groop; Lise Tarnow; Samy Hadjadj Journal: Diabetologia Date: 2014-12-06 Impact factor: 10.122
Authors: Hanni Menn-Josephy; Carol S Lee; Angela Nolin; Marta Christov; Denis V Rybin; Janice M Weinberg; Joel Henderson; Ramon Bonegio; Andrea Havasi Journal: Am J Nephrol Date: 2016-09-15 Impact factor: 3.754
Authors: Merlin C Thomas; Michael Brownlee; Katalin Susztak; Kumar Sharma; Karin A M Jandeleit-Dahm; Sophia Zoungas; Peter Rossing; Per-Henrik Groop; Mark E Cooper Journal: Nat Rev Dis Primers Date: 2015-07-30 Impact factor: 52.329
Authors: Bruce A Perkins; Linda H Ficociello; Bijan Roshan; James H Warram; Andrzej S Krolewski Journal: Kidney Int Date: 2010-01 Impact factor: 10.612
Authors: Frank C Brosius; Charles E Alpers; Erwin P Bottinger; Matthew D Breyer; Thomas M Coffman; Susan B Gurley; Raymond C Harris; Masao Kakoki; Matthias Kretzler; Edward H Leiter; Moshe Levi; Richard A McIndoe; Kumar Sharma; Oliver Smithies; Katalin Susztak; Nobuyuki Takahashi; Takamune Takahashi Journal: J Am Soc Nephrol Date: 2009-09-03 Impact factor: 10.121
Authors: Han Si; Ramandeep S Banga; Pinelopi Kapitsinou; Manjunath Ramaiah; Janis Lawrence; Ganesh Kambhampati; Antje Gruenwald; Erwin Bottinger; Daniel Glicklich; Vivian Tellis; Stuart Greenstein; David B Thomas; James Pullman; Melissa Fazzari; Katalin Susztak Journal: PLoS One Date: 2009-03-11 Impact factor: 3.240
Authors: Niina Sandholm; Amy Jayne McKnight; Rany M Salem; Eoin P Brennan; Carol Forsblom; Valma Harjutsalo; Ville-Petteri Mäkinen; Gareth J McKay; Denise M Sadlier; Winfred W Williams; Finian Martin; Nicolae Mircea Panduru; Lise Tarnow; Jaakko Tuomilehto; Karl Tryggvason; Gianpaolo Zerbini; Mary E Comeau; Carl D Langefeld; Catherine Godson; Joel N Hirschhorn; Alexander P Maxwell; Jose C Florez; Per-Henrik Groop Journal: J Am Soc Nephrol Date: 2013-09-12 Impact factor: 10.121
Authors: Rajasree Menon; Edgar A Otto; Paul Hoover; Sean Eddy; Laura Mariani; Bradley Godfrey; Celine C Berthier; Felix Eichinger; Lalita Subramanian; Jennifer Harder; Wenjun Ju; Viji Nair; Maria Larkina; Abhijit S Naik; Jinghui Luo; Sanjay Jain; Rachel Sealfon; Olga Troyanskaya; Nir Hacohen; Jeffrey B Hodgin; Matthias Kretzler; Kidney Precision Medicine Project Kpmp Journal: JCI Insight Date: 2020-03-26
Authors: Seth Winfree; Pierre C Dagher; Kenneth W Dunn; Michael T Eadon; Michael Ferkowicz; Daria Barwinska; Katherine J Kelly; Timothy A Sutton; Tarek M El-Achkar Journal: Nephron Date: 2018-06-05 Impact factor: 2.847
Authors: Nikhil Singh; Zachary M Avigan; Judith A Kliegel; Brian M Shuch; Ruth R Montgomery; Gilbert W Moeckel; Lloyd G Cantley Journal: JCI Insight Date: 2019-06-20
Authors: Caroline Gluck; Chengxiang Qiu; Sang Youb Han; Matthew Palmer; Jihwan Park; Yi-An Ko; Yuting Guan; Xin Sheng; Robert L Hanson; Jing Huang; Yong Chen; Ae Seo Deok Park; Maria Concepcion Izquierdo; Ioannis Mantzaris; Amit Verma; James Pullman; Hongzhe Li; Katalin Susztak Journal: Nat Commun Date: 2019-06-05 Impact factor: 14.919